Global Neurodegenerative Diseases Market 2015-2019 - Reformulation of Marketed Drugs
DUBLIN, June 02, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/rf4hfn/global) has announced the addition of the "Global Neurodegenerative Diseases Market 2015-2019" report to their offering.
The global neurodegenerative diseases market to grow at a CAGR of 4.77% over the period 2014-2019.
This report covers the present scenario and the growth prospects of the global neurodegenerative diseases market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of neurodegenerative diseases.
According to the EU JPND, neurodegenerative diseases refer to conditions that involve the neurons in the brain. These conditions can affect balance, movement, speech, and respiratory and cardiac functions. They can be inherited or be of unknown etiology.
Reformulation of already marketed drugs is expected to propel market growth during the forecast period. Reformulation is aimed at reducing the side effects of conventional drugs to increase patient compliance and their sales.
According to the report, high unmet medical needs such as the absence of safe, effective, and affordable treatment options have a negative impact on market growth. In addition, no known cure exists for neurodegenerative diseases and the available drugs only provide symptomatic relief.
Further, the report states that the growing generic erosion of already marketed drugs restricts the growth of the market.
The market includes data from the sales of various drugs used in the treatment of:
- Alzheimer's Disease
- Parkinson's Disease
- Multiple Sclerosis
- Epilepsy
- Huntington's Disease
- Amyotrophic Lateral Sclerosis
Key vendors
- Biogen Idec
- Merck Serono
- Novartis
- Pfizer
- Teva Pharmaceutical Industries
- UCB
Key Topics Covered:
- Executive Summary
- List of Abbreviations
- Scope of the Report
- Product Profiles
- Market Research Methodology
- Introduction
- Market Landscape
- Segmentation of Global Neurodegenerative Diseases Market by Type of Disease
- Global Multiple Sclerosis Market
- Global Alzheimer's Disease Market
- Global Epilepsy Market
- Global Parkinson's Disease Market
- Global Huntington's Disease Market
- Global Amyotrophic Lateral Sclerosis Market
- Segmentation of Global Neurodegenerative Diseases Market by Type of Molecule
- Segmentation of Global Neurodegenerative Diseases Market by Route of Administration
- Geographical Segmentation
- Buying Criteria
- Market Growth Drivers
- Drivers and their Impact
- Market Challenges
- Impact of Drivers and Challenges
- Market Trends
- Trends and their Impact
- Vendor Landscape
- Key Vendor Analysis
For more information visit http://www.researchandmarkets.com/research/rf4hfn/global
Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net
Share this article